furosemide has been researched along with penbutolol in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (57.14) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Caron, G; Ermondi, G | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Gottschalk, R; Sistovaris, N | 1 |
| Lawrence, J; Mertens, H; Rössner, M; Vander Elst, E | 1 |
| Chadha, DR; Houtzagers, JJ | 1 |
| Teiwes, F | 1 |
| Graml, W | 1 |
| Grigoleit, HG; Hajdu, P; Heptner, W; Hundt, HK; Meyer, BH; Müller, FO | 1 |
| Graml, W; Haeringer, E; Rangoonwala, B; Roessner, M | 1 |
| Adam, WE; Bitter, F; Geffers, H; Kress, P; Nechwatal, W; Sigel, H; Stauch, M | 1 |
1 review(s) available for furosemide and penbutolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 trial(s) available for furosemide and penbutolol
| Article | Year |
|---|---|
Penbutolol in hypertension, alone and in combination with furosemide. A long-term multicentre study.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Drug Therapy, Combination; Female; Furosemide; Heart Rate; Humans; Hypertension; Male; Middle Aged; Penbutolol; Propanolamines; Tears | 1983 |
A comparison of a combination of penbutolol and frusemide with the two compounds individually in the treatment of hypertension.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Drug Therapy, Combination; Furosemide; Humans; Hypertension; Middle Aged; Penbutolol; Propanolamines; Random Allocation | 1983 |
[3-step plan for the treatment of hypertension].
Topics: Adult; Aged; Antihypertensive Agents; Clinical Trials as Topic; Drug Therapy, Combination; Female; Furosemide; Humans; Hypertension; Male; Middle Aged; Penbutolol | 1982 |
Penbutolol and furosemide in a fixed-dose combination-bio-equivalence of two formulations.
Topics: Adult; Biological Availability; Clinical Trials as Topic; Drug Combinations; Furosemide; Humans; Kinetics; Male; Penbutolol; Propanolamines; Tablets | 1981 |
9 other study(ies) available for furosemide and penbutolol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Protein binding studies of furosemide and penbutolol.
Topics: Blood Proteins; Buffers; Chromatography, Thin Layer; Dialysis; Furosemide; Humans; In Vitro Techniques; Kinetics; Penbutolol; Propanolamines; Protein Binding; Ultrafiltration | 1985 |
[Experience with a fixed beta-blocker-diuretic combination in the treatment of high blood pressure].
Topics: Adult; Aged; Blood Pressure; Dihydralazine; Drug Combinations; Drug Therapy, Combination; Female; Furosemide; Humans; Hypertension; Male; Middle Aged; Penbutolol; Propanolamines; Pulse | 1983 |
Efficacy of penbutolol and a fixed combination of penbutolol with furosemide in the treatment of hypertension.
Topics: Adult; Aged; Blood Pressure; Body Weight; Drug Combinations; Female; Furosemide; Heart Rate; Humans; Hypertension; Male; Middle Aged; Penbutolol; Propanolamines | 1982 |
[Global and regional left ventricular function in coronary heart disease after beta-blockade and furosemide (author's transl)].
Topics: Adult; Coronary Disease; Furosemide; Heart; Heart Ventricles; Humans; Middle Aged; Penbutolol; Physical Exertion; Propanolamines | 1980 |